STOCK TITAN

NanoString Technologies, Inc. - NSTG STOCK NEWS

Welcome to our dedicated page for NanoString Technologies news (Ticker: NSTG), a resource for investors and traders seeking the latest updates and insights on NanoString Technologies stock.

NanoString Technologies, Inc. (NASDAQ: NSTG) drives advancements in life science research and molecular diagnostics through its innovative tools like the nCounter® Analysis System. This page aggregates official updates, financial disclosures, and critical developments impacting the company’s trajectory.

Access real-time announcements including product launches, patent litigation updates, and strategic partnerships. Investors gain insights into operational milestones, while researchers track applications in oncology, immunology, and neuroscience studies.

Discover coverage of earnings reports, regulatory filings, and scientific breakthroughs validated by 300+ peer-reviewed studies. Our neutral reporting ensures you stay informed without promotional bias.

Bookmark this page for streamlined access to NSTG’s evolving story. Check back regularly updated content to support data-driven decisions in biotech investing and research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.72%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.13%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.02%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.02%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.32%
Tags
none
-
Rhea-AI Summary

NanoString Technologies (NASDAQ:NSTG) announced its upcoming first quarter 2023 operating results, scheduled for release on May 3, 2023, post-market close. Following the announcement, a conference call will be held at 4:30 pm ET for management to discuss the results and provide a business update. Interested participants are encouraged to register in advance via NanoString's official website. A replay of the call will be accessible from May 3, 2023, at 7:30 pm ET until May 17, 2023. NanoString is recognized for its innovative tools in life sciences, notably its spatial biology solutions, including the GeoMx® Digital Spatial Profiler and the CosMx™ Spatial Molecular Imager.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.52%
Tags
none
-
Rhea-AI Summary

NanoString Technologies (NSTG) announced equity inducement awards for 16 new employees, granting a total of 144,767 restricted stock units (RSUs) on March 4, 2023. These awards, approved by the Compensation and Human Capital Committee, will vest in three parts over three years. The RSUs are outside of the company's current equity plan but align with the terms of their 2022 Equity Incentive Plan. This move aims to attract top talent as NSTG continues to enhance its life science tools, particularly in spatial biology and molecular imaging.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.65%
Tags
none
Rhea-AI Summary

NanoString Technologies (NASDAQ:NSTG) announced participation in the panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery,” at the 43rd Annual Cowen Health Care Conference from March 6-8, 2023. CEO Brad Gray will be among the panelists on March 7, 2023, from 2:10-3:10 pm ET. Key participants include Kimberly Powell from NVIDIA (NASDAQ:NVDA) and Molly Gibson from Generate Biomedicines. Interested parties can access a live webcast on NanoString's investor website, with a replay available for 30 days post-event. NanoString is known for its innovative solutions in spatial biology, including the GeoMx and AtoMx platforms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.02%
Tags
conferences
NanoString Technologies, Inc.

Nasdaq:NSTG

NSTG Rankings

NSTG Stock Data

5.07M
39.41M
3.17%
106.45%
12.55%
Medical Instruments & Supplies
Healthcare
Link
United States
Seattle